Pellets
Pellestisation is an agglomeration process, that converts fine powder-blend(s) & excipients into small-free flowing, spherical units referred to as PELLETS.
WHY PELLETS SHOULD BE PREFERRED
- Excellent stability
- Compact structure
- Drug absorption
- Release of action at specially targeted site
- High active ingredient content possible
- Controlled release application
- These pellets avoid local irritation of GASTRO INTESTINAL TRACT(GIT) because the drugs doesn’t settle down at one place
ANTI-ALLERGIC
PRODUCT | COMPOSITION |
ANTI ALLERGIC | |
CETIRIZINE HYDROCHLORIDE 15%W/W PELLETS | 15% |
ANTI-BACTERIAL AGENT
PRODUCT | COMPOSITION |
ANTI BACTERIAL AGENT | |
MINOCYCLINE HYDROCHLORIDE 35% W/W PELLETS | 35% |
ANTI-CONVULSANT/ENZYME INHIBITOR
PRODUCT | COMPOSITION |
ANTI CONVULSANT/ENZYME INHIBITOR | |
VALPROIC ACID | 58mg,87mg |
SODIUM VALPORATE | 133mg,200mg |
ANALGESIC
PRODUCT | COMPOSITION |
Analgesic | |
ACECLOFENAC SODIUM 60% W/W SUSTAINED RELEASE PELLETS(FOR DOMESTIC & EXPORT) | 60% |
ACECLOFENAC SODIUM 40% W/W SUSTAINED RELEASE PELLETS(FOR DOMESTIC & EXPORT) | 40% |
DICLOFENAC SODIUM PELLET 40% w/w IN SUSTAINES RELEASE FORM | 40% |
DICLOFENAC POTASSIUM 50% W/W EXTENDED RELEASE PELL | 50% |
INDOMETHACIN EXTENDED RELEASE 30% W/W PELLETS | 30% |
ANTI-DEPRESANT
PRODUCT | COMPOSITION |
ANTI DEPRESANT | |
VENLAFAXINE HYDROCHLORIDE 25% SR | 25% |
DULOXETINE HYDROCHLORIDE 10 % W/W ENTERIC COATED PELLETS | 10% |
ANTI-EMETIC
PRODUCT | COMPOSITION |
ANTI-EMETIC | |
DOMPERIDONE(SUSTAINED RELEASE) PELLETS | 20 mg |
DOMPERIDONE(IMMEDIATE RELEASE) PELLETS | 10 mg |
DOMPERIDONEPELLETS (SUSTAINED RELEASE) | 30mg |
ANTI-FUNGAL AGENTS
PRODUCT | COMPOSITION |
Antifungal Agents | |
ITRACONAZOLE PELLETS 22% W/W | 22% |
ANTI-PLATELET
PRODUCT | COMPOSITION |
Anti-platelet | |
CLOPIDOGREL PELLETS 75 MG | 75mg |
CLOPIDROGREL PELLETS 50% W/W, 55% W/W | 50,55% |
ASPRIN 28% w/w, 60% w/w | |
ROSUVASTATIN 10mg(IR) PELLETS |
ANTI-SPASMODIC
PRODUCT | COMPOSITION |
ANTI SPASMODIC | |
MEBEVERINE HYDROCHLORIDE 40% W/W SR PELLETS | 40% |
ANTI-ULCERANT
PRODUCT | COMPOSITION |
Anti-ulcerant | |
OMEPRAZOLE ENTERIC COATED PELLETS 8.5% W/W | 8.50% |
OMEPRAZOLE ENTERIC COATED PELLETS 15.0% W/W | 15% |
LANSOPRAZOLE ENTERIC COATED PELLETS 8.5% W/W | 8.50% |
LANSOPRAZOLE ENTERIC COATED PELLETS 10.0% W/W | 10% |
PANTOPRAZOLE ENTERIC COATED PELLETS 40mg | 40mg |
RABEPRAZOLE ENTERIC COATED PELLETS 20 MG | 20mg |
ESOMEPRAZOLE ENTERIC COATED PELLETS 40 MG | 40mg |
ESOMEPRAZOLE ENTERIC COATED PELLETS 20 MG | 20mg |
CARDIO VASCULAR
PRODUCT | COMPOSITION |
Cardio Vascular | |
ATORVASTATIN PELLETS 10MG, 20MG | 10,20mg |
EXPECTORANT
PRODUCT | COMPOSITION |
EXPECTORANT | |
AMBROXOL HYDROCHLORIDE 40% W/W PELLETS | 40% |
GOUTSUPRESSANT, ENZYME INHIBITOR, ANTI METABOLITE
PRODUCT | COMPOSITION |
GOUTSUPRESSANT, ENZYME INHIBITOR, ANTI METABOLITE | |
ALLOPURINOL 70% W/W SUSTAINED RELEASE PELLETS | 70% |
HYPOLIPIDEMIC AGENT
PRODUCT | COMPOSITION |
HYPOLIPIDEMIC AGENT | |
FENOFIBRATE 66% W/W PELLETS | 66% |
PREMATURE EJACULATION
PRODUCT | COMPOSITION |
Premature Ejaculation | |
DAPOXETINE HYDROCHLORIDE 11% , 22% W/W | 11,22% |
PROKINETIC AGENT
PRODUCT | COMPOSITION |
Prokinetic agent | |
ITOPRIDE HCL SR PELLETS 150 MG | 150mg |
PROTONPUMP INHIBITOR
PRODUCT | COMPOSITION |
PROTONPUMP INHIBITOR | |
DEXLANSOPRAZOLE 20% W/W PELLETS | 20% |
DEXRABEPRAZOLE 20% W/W PELLETS | 20% |